CORT Q2 2020 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$89M+22.6% YoY

Gross Profit

$87M98.6% margin

Operating Income

$35M39.8% margin

Net Income

$28M32.0% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

-5.0%

Cash Flow

Operating Cash Flow

$53M

Free Cash Flow

$53M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$498M

Total Liabilities

$44M

Stockholders' Equity

$454M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$72M	+22.6%
Gross Profit	$87M	$71M	+23.2%
Operating Income	$35M	$25M	+43.1%
Net Income	$28M	$20M	+40.3%